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LETTER TO THE EDITOR
Radiotherapy in high grade gliomas
Sir-Your Guest Editorial on 'Radiotherapy in high grade
gliomas' (Brada, 1989) provides a balanced overview but
perpetuates a misconception in one statement. The BTSG
randomised studies frequently quoted as evidence of a radia-
tion dose-response relationship between 50 and 60 Gy were
not randomised for dose. The relationship was retrospectively
reconstructed from a succession of three protocols in which
patients received differing radiation doses (Walker et al.,
1979). It is now well recognised that imbalances in significant
prognostic factors may alter such conclusions. It is for this
reason that this important question of a dose response was
addressed in a recent MRC Brain Tumour Working Party
study comparing 45 Gy (20 fractions in 4 weeks) versus
60 Gy (30 fractions in 6 weeks with the last 10 fractions given
to a boost volume only). This study closed in November
1988, with a case entry of 474 patients and will be presented
for analysis and publication after 1-year complete follow-up.
Yours etc.,
N.M. Bleehen & S. Stenning,
MRC Clinical Oncology & Radiotherapeutics Unit,
Medical Research Council Centre,
Hills Road,
Cambridge CB2 2QH, UK.
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